200 related articles for article (PubMed ID: 24825325)
1. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
[TBL] [Abstract][Full Text] [Related]
2. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
3. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
[TBL] [Abstract][Full Text] [Related]
4. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
[TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
6. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
[TBL] [Abstract][Full Text] [Related]
7. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin.
BelAiba RS; Djordjevic T; Bonello S; Artunc F; Lang F; Hess J; Görlach A
Circ Res; 2006 Mar; 98(6):828-36. PubMed ID: 16484615
[TBL] [Abstract][Full Text] [Related]
8. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
[TBL] [Abstract][Full Text] [Related]
9. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT
Su H; Xu X; Yan C; Shi Y; Hu Y; Dong L; Ying S; Ying K; Zhang R
Respir Res; 2018 Dec; 19(1):254. PubMed ID: 30547791
[TBL] [Abstract][Full Text] [Related]
10. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
[TBL] [Abstract][Full Text] [Related]
11. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
Tang C; Luo Y; Li S; Huang B; Xu S; Li L
Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
[TBL] [Abstract][Full Text] [Related]
14. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Zopf DA; das Neves LA; Nikula KJ; Huang J; Senese PB; Gralinski MR
Eur J Pharmacol; 2011 Nov; 670(1):195-203. PubMed ID: 21914448
[TBL] [Abstract][Full Text] [Related]
15. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.
Lin J; Chen R; Liao H; Zhang Y; Zheng Z; Hong C
Sci Rep; 2024 May; 14(1):12431. PubMed ID: 38816406
[TBL] [Abstract][Full Text] [Related]
17. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension.
Chen L; Nakano K; Kimura S; Matoba T; Iwata E; Miyagawa M; Tsujimoto H; Nagaoka K; Kishimoto J; Sunagawa K; Egashira K
Hypertension; 2011 Feb; 57(2):343-50. PubMed ID: 21220711
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Ito T; Okada T; Miyashita H; Nomoto T; Nonaka-Sarukawa M; Uchibori R; Maeda Y; Urabe M; Mizukami H; Kume A; Takahashi M; Ikeda U; Shimada K; Ozawa K
Circ Res; 2007 Sep; 101(7):734-41. PubMed ID: 17673672
[TBL] [Abstract][Full Text] [Related]
20. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]